Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 11/20 | 0.75 |
| ▸ | CA9 | Q16790 | 11/20 | 0.75 |
| ▸ | CA1 | P00915 | 10/20 | 0.75 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | CA6 | P23280 | 5/20 | 0.67 |
| ▸ | CA7 | P43166 | 5/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.67 |
| ▸ | CA4 | P22748 | 5/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.67 |
| ▸ | CA5A | P35218 | 3/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 3/20 | 0.63 |
| ▸ | CA3 | P07451 | 3/20 | 0.63 |
| ▸ | MAOB | P27338 | 5/20 | 0.61 |
| ▸ | MAOA | P21397 | 4/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 7-Allyloxycoumarin SCHEMBL4765530 | 0.86 | CA12 (1.00) | CA12CA9CA1MTNR1AKDM4E | |
| SCHEMBL14403149 | 0.84 | CA12 (0.68) | CA12CA9CA1MTNR1AKDM4E | |
| (E)-7-(2-Butenyloxy)Coumarin SCHEMBL12189889 | 0.83 | CA12 (0.69) | CA12CA9CA1MTNR1AKDM4E | |
| (E)-7-(2-Butenyloxy)Coumarin SCHEMBL18284641 | 0.83 | CA12 (0.69) | CA12CA9CA1MTNR1AKDM4E | |
| SCHEMBL12304245 | 0.83 | CA12 (0.81) | CA12CA9CA1MTNR1AKDM4E | |
| SCHEMBL12189883 | 0.82 | CA12 (0.68) | CA12CA9CA1MTNR1AKDM4E | |
| SCHEMBL12189878 | 0.82 | CA12 (0.68) | CA12CA9CA1MTNR1AKDM4E | |
| SCHEMBL12189886 | 0.82 | CA12 (0.68) | CA12CA9CA1MTNR1AKDM4E | |
| 7-Prenyloxycoumarin SCHEMBL4898255 | 0.82 | KDM4E (1.00) | CA12CA9CA1MTNR1AKDM4E | |
| SCHEMBL29999425 | 0.80 | NDUFS8 (0.83) | CA12CA9CA1MTNR1AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230200386-A1 | MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS HERBICIDES | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2023-06-29 | — | — | US | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| US-7427680-B2 | Fluorogenic substrates for BETA-lactamase gene expression | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-23 | — | — | US | disclosed |
| US-7427680-B2 | Fluorogenic substrates for BETA-lactamase gene expression | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-23 | — | — | US | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200386-A1 | MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS HERBICIDES | DDT, CYP4B1, GSTO1 | CA12 2533/4885CA9 2844/4885CA1 1211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.